NYSE · CIK 0001179929
MOH MOLINA HEALTHCARE, INC.
Insider trading from SEC Form 4. Last filing 10 d ago. Close $196.93 on Oct 9, 2026, +61% from the 52-week low and -19% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
16
with a Form 4 at this company
Price and insider trades, last year
MOHOct 9, 2026 · close 196.93
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at MOLINA HEALTHCARE, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Ronna Romney director sell | $108k 700 shares | -4% | 0% from low-58% from high | |
| 66Notable | James Woys Chief Operating Officer buy | $1.6M 10,000 shares | +16% | +2% from low-56% from high | |
| 33Weak | Dale B Wolf director sell | $484k 1,500 shares | -10% | +20% from low-11% from high | |
| 44Moderate | Steven J Orlando director sell | $319k 1,000 shares | -6% | +20% from low-11% from high | |
| 75Notable | Joseph M Zubretsky President & CEO sell | $28M 87,500 shares | -25% | +23% from low-9% from high | |
| 42Moderate | Richard M Schapiro director sell | $214k 669 shares | -6% | +20% from low-11% from high | |
| 21Weak | Richard M Schapiro director sell | $40k 136 shares | -1% | - |
Congressional trades
8 trades in MOH disclosed by members of Congress under the STOCK Act. All congressional trades.
- Gilbert Ray Cisneros, Jr.House · D-CA · last Dec 15, 20252 bought
2 sold - Byron DonaldsHouse · R-FL · last Oct 7, 20250 bought
2 sold - Robert P. Bresnahan, Jr.House · R-PA · last Jun 9, 20251 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | MOH Molina Healthcare Inc Common Stock | $1,001 to $15k | Nov 12, 2025 / Dec 15, 2025 33 days after the trade | Clerk |
Byron Donalds House · R-FL | Sale | MOH Molina Healthcare Inc Common Stock | $1,001 to $15k | Sep 4, 2025 / Oct 7, 2025 33 days after the trade | Clerk |
Byron Donalds House · R-FL | Sale | MOH Molina Healthcare Inc Common Stock | $1,001 to $15k | Sep 4, 2025 / Oct 7, 2025 33 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | MOH Molina Healthcare Inc Common Stock | $1,001 to $15k | Aug 5, 2025 / Sep 12, 2025 38 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Purchase | MOH Molina Healthcare Inc Common Stock | $1,001 to $15k | May 15, 2025 / Jun 9, 2025 25 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | MOH Molina Healthcare Inc Common Stock | $1,001 to $15k | May 30, 2025 / Jun 6, 2025 7 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | MOH Molina Healthcare Inc Common Stock | $1,001 to $15k | Apr 29, 2025 / May 6, 2025 7 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Sale | MOH Molina Healthcare Inc Common Stock | $1,001 to $15k | Jan 13, 2025 / Feb 13, 2025 31 days after the trade | Clerk |
Transactions
The last 63 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Leo P Grohowski director | AGrant or award Common Stock | +304 | $180.85 | $55k | 1,846 | 10 d ago |
| Oct 1, 2026 | Barbara L Brasier director | AGrant or award Common Stock | +304 | $180.85 | $55k | 6,122 | 10 d ago |
| Oct 1, 2026 | Richard M Schapiro director | AGrant or award Common Stock | +304 | $180.85 | $55k | 12,615 | 10 d ago |
| Oct 1, 2026 | Richard C Zoretic director | AGrant or award Common Stockindirect: Held by trust | +304 | $180.85 | $55k | 9,693 | 10 d ago |
| Oct 1, 2026 | Francis S Soistman Jr director | AGrant or award Common Stock | +304 | $180.85 | $55k | 1,211 | 10 d ago |
| Oct 1, 2026 | Steven J Orlando director | AGrant or award Common Stockindirect: Held by trust | +304 | $180.85 | $55k | 18,271 | 10 d ago |
| Oct 1, 2026 | Ronna Romney director | AGrant or award Common Stockindirect: Held by trust | +304 | $180.85 | $55k | 18,173 | 10 d ago |
| Oct 1, 2026 | Stephen H Lockhart director | AGrant or award Common Stock | +304 | $180.85 | $55k | 4,688 | 10 d ago |
| Oct 1, 2026 | Dale B Wolf director | AGrant or award Common Stockindirect: Held by Trust | +304 | $180.85 | $55k | 15,937 | 10 d ago |
| Oct 1, 2025 | Barbara L Brasier director | AGrant or award Common Stock | +285 | $192.79 | $55k | 4,859 | Oct 2, 2025 |
| Aug 6, 2025 | Ronna Romney director | SOpen-market sale Common Stockindirect: Held by trust | -700 | $153.74 | $108k | 17,131 | Aug 8, 2025 |
| Aug 4, 2025 | James Woys Chief Operating Officer | POpen-market purchase Common Stock | +5,500 | $155.59 | $856k | 69,831 | Aug 6, 2025 |
| Aug 4, 2025 | James Woys Chief Operating Officer | POpen-market purchase Common Stock | +4,500 | $156.36 | $704k | 74,331 | Aug 6, 2025 |
| Jul 1, 2025 | Ronna Romney director | AGrant or award Common Stockindirect: Held by trust | +180 | $306.29 | $55k | 17,831 | Jul 2, 2025 |
| Jun 30, 2025 | James Woys Chief Operating Officer | AGrant or award Common Stock | +85 | $247.39 | $21k | 64,331 | Jul 2, 2025 |
| Jun 30, 2025 | Jeff D. Barlow Chief Legal Officer | AGrant or award Common Stock | +85 | $247.39 | $21k | 72,902 | Jul 2, 2025 |
| Jun 30, 2025 | Debra Bacon EVP, Medicaid | AGrant or award Common Stock | +41 | $247.39 | $10k | 13,067 | Jul 2, 2025 |
| Jul 1, 2025 | Richard C Zoretic director | AGrant or award Common Stockindirect: Held by trust | +180 | $306.29 | $55k | 7,345 | Jul 2, 2025 |
| Jul 1, 2025 | Dale B Wolf director | AGrant or award Common Stockindirect: Held by Trust | +180 | $306.29 | $55k | 14,389 | Jul 2, 2025 |
| Jul 1, 2025 | Richard M Schapiro director | AGrant or award Common Stock | +180 | $306.29 | $55k | 11,424 | Jul 2, 2025 |
| Jul 1, 2025 | Steven J Orlando director | AGrant or award Common Stockindirect: Held by trust | +180 | $306.29 | $55k | 16,723 | Jul 2, 2025 |
| Jul 1, 2025 | Stephen H Lockhart director | AGrant or award Common Stock | +180 | $306.29 | $55k | 3,140 | Jul 2, 2025 |
| Jul 1, 2025 | Leo P Grohowski director | AGrant or award Common Stock | +180 | $306.29 | $55k | 298 | Jul 2, 2025 |
| Jul 1, 2025 | Barbara L Brasier director | AGrant or award Common Stock | +180 | $306.29 | $55k | 4,574 | Jul 2, 2025 |
| Jul 1, 2025 | Debra Bacon EVP, Medicaid | FTax withholding Common Stock | -183 | $306.29 | $56k | 12,884 | Jul 2, 2025 |
| May 21, 2025 | Dale B Wolf director | SOpen-market sale Common Stockindirect: Held by Trust | -100 | $320.51 | $32k | 15,609 | May 22, 2025 |
| May 21, 2025 | Dale B Wolf director | SOpen-market sale Common Stockindirect: Held by Trust | -400 | $322.23 | $129k | 15,209 | May 22, 2025 |
| May 21, 2025 | Dale B Wolf director | SOpen-market sale Common Stockindirect: Held by Trust | -900 | $323.27 | $291k | 14,309 | May 22, 2025 |
| May 21, 2025 | Dale B Wolf director | SOpen-market sale Common Stockindirect: Held by Trust | -100 | $324.42 | $32k | 14,209 | May 22, 2025 |
| May 5, 2025 | Steven J Orlando director | SOpen-market sale Common Stockindirect: Held by trust | -1,000 | $318.58 | $319k | 16,543 | May 5, 2025 |
| Apr 30, 2025 | Joseph M Zubretsky President & CEO | SOpen-market sale Common Stockindirect: Held by Trust | -86,400 | $320.00 | $28M | 258,815 | May 2, 2025 |
| May 1, 2025 | Leo P Grohowski director | AGrant or award Common Stock | +118 | $313.04 | $37k | 118 | May 2, 2025 |
| Apr 30, 2025 | Joseph M Zubretsky President & CEO | SOpen-market sale Common Stockindirect: Held by Trust | -1,100 | $324.70 | $357k | 257,715 | May 2, 2025 |
| Apr 29, 2025 | Richard M Schapiro director | SOpen-market sale Common Stock | -669 | $320.50 | $214k | 11,244 | May 1, 2025 |
| Apr 1, 2025 | Dale B Wolf director | AGrant or award Common Stock | +168 | $327.71 | $55k | 15,709 | Apr 2, 2025 |
| Apr 1, 2025 | Richard C Zoretic director | AGrant or award Common Stockindirect: Held by trust | +168 | $327.71 | $55k | 7,165 | Apr 2, 2025 |
| Apr 1, 2025 | Richard M Schapiro director | AGrant or award Common Stock | +168 | $327.71 | $55k | 11,913 | Apr 2, 2025 |
| Apr 1, 2025 | Ronna Romney director | AGrant or award Common Stockindirect: Held by trust | +168 | $327.71 | $55k | 17,651 | Apr 2, 2025 |
| Apr 1, 2025 | Steven J Orlando director | AGrant or award Common Stockindirect: Held by trust | +168 | $327.71 | $55k | 17,543 | Apr 2, 2025 |
| Apr 1, 2025 | Stephen H Lockhart director | AGrant or award Common Stock | +168 | $327.71 | $55k | 2,960 | Apr 2, 2025 |
| Apr 1, 2025 | Daniel Cooperman director | AGrant or award Common Stock | +56 | $327.71 | $18k | 6,383 | Apr 2, 2025 |
| Apr 1, 2025 | Barbara L Brasier director | AGrant or award Common Stock | +168 | $327.71 | $55k | 4,394 | Apr 2, 2025 |
| Mar 1, 2025 | Debra Bacon EVP, Medicaid | AGrant or award Common Stock | +6,605 | $301.12 | $2.0M | 12,673 | Mar 4, 2025 |
| Mar 1, 2025 | Mark Lowell Keim Chief Financial Officer | AGrant or award Common Stock | +10,748 | $301.12 | $3.2M | 58,342 | Mar 4, 2025 |
| Mar 1, 2025 | Jeff D. Barlow Chief Legal Officer | AGrant or award Common Stock | +7,882 | $301.12 | $2.4M | 74,030 | Mar 4, 2025 |
| Mar 1, 2025 | Maurice Hebert Chief Accounting Officer | AGrant or award Common Stock | +1,792 | $301.12 | $540k | 11,265 | Mar 4, 2025 |
| Mar 1, 2025 | Jeff D. Barlow Chief Legal Officer | FTax withholding Common Stock | -4,221 | $301.12 | $1.3M | 69,809 | Mar 4, 2025 |
| Mar 1, 2025 | Mark Lowell Keim Chief Financial Officer | FTax withholding Common Stock | -5,053 | $301.12 | $1.5M | 53,289 | Mar 4, 2025 |
| Mar 1, 2025 | Maurice Hebert Chief Accounting Officer | FTax withholding Common Stock | -656 | $301.12 | $198k | 10,609 | Mar 4, 2025 |
| Mar 1, 2025 | Debra Bacon EVP, Medicaid | FTax withholding Common Stock | -2,270 | $301.12 | $684k | 10,403 | Mar 4, 2025 |
| Mar 1, 2025 | Jeff D. Barlow Chief Legal Officer | FTax withholding Common Stock | -1,851 | $301.12 | $557k | 67,958 | Mar 4, 2025 |
| Mar 1, 2025 | Maurice Hebert Chief Accounting Officer | FTax withholding Common Stock | -303 | $301.12 | $91k | 10,306 | Mar 4, 2025 |
| Mar 1, 2025 | Debra Bacon EVP, Medicaid | FTax withholding Common Stock | -431 | $301.12 | $130k | 9,972 | Mar 4, 2025 |
| Mar 1, 2025 | Mark Lowell Keim Chief Financial Officer | FTax withholding Common Stock | -2,480 | $301.12 | $747k | 50,809 | Mar 4, 2025 |
| Mar 1, 2025 | Jeff D. Barlow Chief Legal Officer | AGrant or award Common Stock | +4,859 | $288.12 | $1.4M | 72,817 | Mar 4, 2025 |
| Mar 1, 2025 | Debra Bacon EVP, Medicaid | AGrant or award Common Stock | +3,054 | $288.12 | $880k | 13,026 | Mar 4, 2025 |
| Mar 1, 2025 | Maurice Hebert Chief Accounting Officer | AGrant or award Common Stock | +902 | $288.12 | $260k | 11,208 | Mar 4, 2025 |
| Mar 1, 2025 | Mark Lowell Keim Chief Financial Officer | AGrant or award Common Stock | +8,677 | $288.12 | $2.5M | 59,486 | Mar 4, 2025 |
| Jan 1, 2025 | Barbara L Brasier director | AGrant or award Common Stock | +189 | $291.05 | $55k | 4,226 | Jan 2, 2025 |
| Jan 1, 2025 | Daniel Cooperman director | AGrant or award Common Stock | +189 | $291.05 | $55k | 6,327 | Jan 2, 2025 |
| Dec 31, 2024 | Debra Bacon EVP, Medicaid | AGrant or award Common Stock | +13 | $247.39 | $3,216 | 6,518 | Jan 2, 2025 |
| Jan 1, 2025 | Debra Bacon EVP, Medicaid | FTax withholding Common Stock | -450 | $291.05 | $131k | 6,068 | Jan 2, 2025 |
| Nov 18, 2024 | Richard M Schapiro director | SOpen-market sale Common Stock | -136 | $292.72 | $40k | 11,556 | Nov 19, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Barbara L Brasierdirector
- Debra BaconEVP, Medicaid
- Jeff D. BarlowChief Legal Officer
- Daniel Coopermandirector
- Leo P Grohowskidirector
- Maurice HebertChief Accounting Officer
- Mark Lowell KeimChief Financial Officer
- Stephen H Lockhartdirector
- Steven J Orlandodirector
- Ronna Romneydirector
- Francis S Soistman Jrceo, officer, director
- Richard M Schapirodirector
- Dale B Wolfdirector
- James WoysChief Operating Officer
- Richard C Zoreticdirector
- Joseph M ZubretskyPresident & CEO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.